3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
10
Breast Neoplasms
10
Prostatic Neoplasms
9
Neoplasms
7
Hematopoietic and Lymphatic System Neoplasm
7
Multiple Myeloma
3
Lymphoma
3
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Mouth Neoplasms
2
Malignant Solid Neoplasm
2
Lung Neoplasms
2
Leukemia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Hematopoietic and Lymphoid System Neoplasm
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Prostate Cancer Patients
1
Interventions
Magnetic Resonance Spectroscopy
4
Surgical Procedures, Operative
3
Iodine-131
3
Iodine-124
3
Biopsy
3
selpercatinib
2
lenvatinib
2
Watchful Waiting
2
Thyrotropin Alfa
2
Therapeutics
2
Nivolumab
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Cetuximab
2
Biopsy, Fine-Needle
2
trastuzumab deruxtecan
1
trametinib
1
sintilimab
1
sacituzumab govitecan
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
gallium Ga 68 dotatate
1
fludarabine phosphate
1
defactinib
1
dabrafenib
1
cemiplimab
1
brodalumab
1
binimetinib
1
anlotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Thyroid Neoplasms
×
Interviews as Topic
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled